News & Updates

20-µg hep B vaccine can prevent vertical transmission
20-µg hep B vaccine can prevent vertical transmission
23 Jul 2022
SG: COPD severity a key factor when choosing between therapies
SG: COPD severity a key factor when choosing between therapies
22 Jul 2022 byJairia Dela Cruz

Chronic obstructive pulmonary disease (COPD) patients initiating treatment with a long-acting muscarinic antagonist (LAMA) plus a long-acting β2-agonist (LABA) tend to have higher disease severity than those who are started on LAMA, according to real-world data from Singapore. However, there are as many patients who experience clinical worsening in the LAMA group as there are in the LAMA+LABA group.

SG: COPD severity a key factor when choosing between therapies
22 Jul 2022
HCV treatment helps prevent cirrhosis, death in persons who inject drugs
HCV treatment helps prevent cirrhosis, death in persons who inject drugs
22 Jul 2022
Apremilast more efficacious in PsA patients with moderate vs high disease activity
Apremilast more efficacious in PsA patients with moderate vs high disease activity
22 Jul 2022 byStephen Padilla

Psoriatic arthritis (PsA) patients with moderate disease activity (MDA) at baseline who are treated with apremilast are more likely to achieve treatment targets than those with high disease activity (HDA), a recent study has shown.

Apremilast more efficacious in PsA patients with moderate vs high disease activity
22 Jul 2022